The Federal Government Wants to Make a List of Covid Vaccine Injuries
RFK Jr. wants to create a federal catalog of presumed Covid-19 vaccine injuries, a move that could help legitimately harmed patients or validate scientifically unsupported claims. The proposed rule drops in November, and everyone from Wall Street to the CDC is bracing for the fallout.
Imagine filing an insurance claim, but instead of proving someone rear-ended you, you just have to show the dent and the date. That's roughly the idea behind a "vaccine injury table," and Robert F. Kennedy Jr. wants to build one for Covid-19 vaccines.
The HHS Secretary announced plans to create a formal catalog of injuries presumed to be caused by Covid-19 vaccines and related treatments. A proposed rule is expected in November 2026, with a public comment period stretching into early 2027. The details (which injuries, which time windows, which products) haven't been published yet. But the framework alone is already stirring up a fight between public health experts, vaccine skeptics, legal advocates, and Wall Street.
How an Injury Table Actually Works
The concept isn't new. The U.S. already has injury tables for smallpox and H1N1 vaccines. Think of them like a cheat sheet for compensation claims. If you develop a listed condition within a specified number of days after vaccination, the government presumes the vaccine caused it. You don't have to hire an expert witness or wage a years-long legal battle to prove causation.
This matters because the current system is brutal for claimants. Covid-19 vaccine injuries are handled through the Countermeasures Injury Compensation Program (CICP), a separate, more restrictive track than the better-known "vaccine court" system used for childhood shots. Of the roughly 4,111 Covid-related claims decided through April 2025, only 67 were approved. That's a 1.6% success rate. For comparison, the traditional vaccine court compensates about 48% of the petitions it adjudicates.
So yes, the existing system is failing people who may have legitimate injuries. Almost nobody disputes that.
The Part Everyone's Fighting About
The real question isn't whether a Covid injury table should exist. Most mainstream scientists actually agree it should, at least for a narrow set of well-documented side effects. Myocarditis (heart inflammation) after mRNA shots, particularly in young men, is widely acknowledged as a rare but real risk. So is anaphylaxis (severe allergic reaction) and a clotting disorder called TTS linked to the Johnson & Johnson shot.
Get tomorrow's biotech intelligence before your competitors.
Join thousands of biotech professionals who start their day with our free, daily briefing.
A tightly scoped table covering those conditions? Reasonable. Evidence-based. Even overdue.
But this is where Kennedy's track record makes scientists nervous. As HHS Secretary, he's already canceled roughly $500 million in federal mRNA vaccine research, fired all 17 members of the CDC's vaccine advisory committee, and tried to pull vaccines for six diseases off the childhood schedule (a move blocked by a federal judge). He ordered the CDC website changed from stating studies show "no link" between vaccines and autism to saying studies "have not ruled out the possibility."
Pharmaceutical attorney Richard H. Hughes IV has warned that a narrow, evidence-based list would be "consistent with the kind of evidence-based compensation system Congress contemplated." But he also cautioned against including broad neurologic syndromes, chronic fatigue conditions, POTS, autoimmune disorders, or sudden cardiac death theories where the science doesn't support a causal link. If those make the list, Hughes argued, the table becomes a "vehicle for validating unsupported injury narratives" rather than a fair compensation tool.
That's the tightrope. The same mechanism that could help legitimately injured people could also become a federal stamp of approval on claims that don't hold up scientifically.
Why Wall Street Is Watching
Pharmaceutical investors have been pricing in "RFK risk" for over a year now. When Trump first selected Kennedy for HHS, Moderna dropped about 6% in a single day. Pfizer fell about 2-3%. BioNTech and Novavax each slid around 7%.
The pattern has been consistent: every major Kennedy policy move hits mRNA-focused companies harder than diversified pharma. Moderna, still heavily dependent on its mRNA vaccine platform, has seen its stock fall roughly 93% from its peak. Pfizer, with a broader portfolio of drugs across multiple therapeutic areas, absorbs the blows more easily.
The injury table adds another layer of uncertainty. It won't change the legal liability shield that already protects vaccine makers under the PREP Act; that remains intact. But a federally endorsed list of vaccine injuries, especially a broad one, could further erode public confidence in mRNA shots and suppress demand. For a company like Moderna, whose entire identity is built on mRNA technology, that's an existential-level concern.
The VAERS Problem Lurking in the Background
Any conversation about vaccine injuries inevitably runs into VAERS, the Vaccine Adverse Event Reporting System. It's a passive database where anyone (doctors, patients, lawyers, your neighbor) can file a report after vaccination. It's useful as an early warning system, a way to spot unusual patterns worth investigating.
But VAERS cannot prove causation. It has no control group, no reliable way to calculate rates, and is heavily influenced by media coverage and litigation trends. The CDC and FDA have said this repeatedly: a VAERS report does not mean a vaccine caused the event.
Yet raw VAERS counts are routinely cited on social media as proof of widespread vaccine harm. If Kennedy's injury table draws on VAERS data without the rigorous follow-up analyses that FDA and CDC typically perform through stronger systems (like the Vaccine Safety Datalink, which links vaccination records to actual health outcomes), the resulting list could reflect reporting trends more than medical reality.
The statute requires injuries on the table to be supported by "compelling, reliable, valid medical and scientific evidence" — a standard used by the Secretary when creating or amending the table. That phrase is doing a lot of heavy lifting right now. Whether it holds up depends entirely on who's interpreting it.
What Happens Next
The proposed rule drops in November 2026. Public comments will follow. Medical groups, patient advocates, pharmaceutical companies, and anti-vaccine organizations will all weigh in. The final table could be narrow and scientifically defensible, or it could be broad enough to reshape how Americans think about vaccine safety for a generation.
The stakes are real on both sides. Thousands of Covid vaccine injury claims are still pending in the current system, most of them going nowhere under a 1.6% approval rate. Those people deserve a fair process. But a table built to validate a political narrative rather than scientific evidence could do lasting damage to public trust in vaccines that, by the data, have saved millions of lives.
The injury table itself isn't the problem. The question is who's holding the pen.
Clinical & Regulatory5 min read
The Eye Drug That Took Three Rejections to Finally Win Over the FDA
After three FDA rejections and a dramatic appeal that went over the review division's head, Outlook Therapeutics' Lytenava just became the first FDA-approved ophthalmic bevacizumab for wet AMD. Now comes the harder part: selling it in an $8.5 billion market where doctors have used the off-label version for decades.
